Literature DB >> 16504807

Clinical features of myomas.

Orhan Bukulmez1, Kevin J Doody.   

Abstract

Uterine myomas are the most common solid pelvic tumors in women and the primary indication for hysterectomy. Most of the myomas are asymptomatic. The most common symptoms associated with uterine myomas are abnormal uterine bleeding and pelvic discomfort mostly caused by the mass effect. Vaginal bleeding may lead to iron deficiency anemia. Uterine myomas have a significant role in reproductive dysfunction, although a causal relationship between infertility and intramural or subserosal myomas not disturbing the uterine cavity has not been established clearly. Nevertheless myomas, especially the tumors distorting the uterine cavity, are associated with infertility and spontaneous miscarriage. In addition, the myomas may be the potential cause for numerous obstetric complications, especially if they are located adjacent to placenta. The transformation of myomas to leiomyosarcomas is a very rare event. Leiomyosarcomas may be suspected in postmenopausal women with rapidly growing symptomatic solid pelvic mass. Despite the high prevalence of these tumors, there is paucity of data available regarding the natural clinical history of myomas.

Entities:  

Mesh:

Year:  2006        PMID: 16504807     DOI: 10.1016/j.ogc.2005.12.002

Source DB:  PubMed          Journal:  Obstet Gynecol Clin North Am        ISSN: 0889-8545            Impact factor:   2.844


  11 in total

Review 1.  Uterine leiomyomas revisited with review of literature.

Authors:  Rishi Philip Mathew; Swati Francis; Vinayak Jayaram; Shameema Anvarsadath
Journal:  Abdom Radiol (NY)       Date:  2021-05-31

2.  Evaluation of Estrogen, Progesterone, and GCDFP-15 Expression in Uterine Leiomyomas.

Authors:  Havva Erdem; Feyza Başar; Nilüfer Kadıoğlu; Murat Oktay; Handan Ankaralı; Ali Yavuzcan; Anzel Bahadır; Serdar Dilbaz
Journal:  J Obstet Gynaecol India       Date:  2014-12-25

3.  Innervation in women with uterine myoma and adenomyosis.

Authors:  Ye Jin Choi; Ji-Ae Chang; Young Ah Kim; Sun Hee Chang; Kyoung Chul Chun; Jae Whoan Koh
Journal:  Obstet Gynecol Sci       Date:  2015-03-16

Review 4.  Epigenomic and enhancer dysregulation in uterine leiomyomas.

Authors:  Oliwia W Mlodawska; Priyanka Saini; J Brandon Parker; Jian-Jun Wei; Serdar E Bulun; Melissa A Simon; Debabrata Chakravarti
Journal:  Hum Reprod Update       Date:  2022-06-30       Impact factor: 17.179

5.  Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer.

Authors:  Laveta Stewart; Gladys M Glenn; Pamela Stratton; Alisa M Goldstein; Maria J Merino; Margaret A Tucker; W Marston Linehan; Jorge R Toro
Journal:  Arch Dermatol       Date:  2008-12

6.  A low concentration of genistein induces estrogen receptor-alpha and insulin-like growth factor-I receptor interactions and proliferation in uterine leiomyoma cells.

Authors:  X Di; L Yu; A B Moore; L Castro; X Zheng; T Hermon; D Dixon
Journal:  Hum Reprod       Date:  2008-05-20       Impact factor: 6.918

7.  The relationship between uterine leiomyomata and pelvic floor symptoms.

Authors:  Christina E Dancz; Priyanka Kadam; Carrie Li; Kristen Nagata; Begüm Özel
Journal:  Int Urogynecol J       Date:  2013-08-07       Impact factor: 2.894

8.  Incorporating ulipristal acetate in the care of symptomatic uterine fibroids: a Canadian cost-utility analysis of pharmacotherapy management.

Authors:  Bernice Tsoi; Gord Blackhouse; Simon Ferrazzi; Clare J Reade; Innie Chen; Ron Goeree
Journal:  Clinicoecon Outcomes Res       Date:  2015-04-17

9.  Treatment of symptomatic uterine fibroids with green tea extract: a pilot randomized controlled clinical study.

Authors:  Eman Roshdy; Veera Rajaratnam; Sarbani Maitra; Mohamed Sabry; Abdou S Ait Allah; Ayman Al-Hendy
Journal:  Int J Womens Health       Date:  2013-08-07

10.  A postmenopausal woman with sciatica from broad ligament leiomyoma: a case report.

Authors:  Ya-Chu May Tsai
Journal:  J Med Case Rep       Date:  2016-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.